News List
May 17, 2021

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases

May 17, 2021
Not intended for U.S. and UK Media - Late-Breaking Data from exploratory analysis of Phase III FIDELIO-DKD study presented at the American College of Cardiology’s (ACC) 70th Annual Scientific Session (ACC.21)

Finerenone has potential to reduce the risk of new onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes

May 17, 2021
Not intended for U.S. and UK Media

Large real-world study shows benefit of rivaroxaban in patients with nonvalvular atrial fibrillation with type 2 diabetes

May 12, 2021
First quarter of 2021:

Bayer: successful start to 2021

May 10, 2021
Not intended for U.S. and UK Media

Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes